David Piwnica‐Worms

26.0k total citations · 4 hit papers
282 papers, 19.5k citations indexed

About

David Piwnica‐Worms is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David Piwnica‐Worms has authored 282 papers receiving a total of 19.5k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Molecular Biology, 96 papers in Oncology and 62 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David Piwnica‐Worms's work include Radiopharmaceutical Chemistry and Applications (32 papers), Drug Transport and Resistance Mechanisms (30 papers) and bioluminescence and chemiluminescence research (24 papers). David Piwnica‐Worms is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (32 papers), Drug Transport and Resistance Mechanisms (30 papers) and bioluminescence and chemiluminescence research (24 papers). David Piwnica‐Worms collaborates with scholars based in United States, Ireland and Italy. David Piwnica‐Worms's co-authors include Julie L. Prior, Seth T. Gammon, James F. Kronauge, Gary D. Luker, Mark L. Chiu, Shimon Gross, Vijay Sharma, Lynne Collins, Helen Piwnica‐Worms and Joel R. Garbow and has published in prestigious journals such as Nature, Chemical Reviews and Proceedings of the National Academy of Sciences.

In The Last Decade

David Piwnica‐Worms

279 papers receiving 19.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glypican-1 identifies cancer exosomes and detects early pancreatic cancer

2015 2.2k citations Sónia A. Melo, Christoph Kahlert et al. Nature profile →
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses

2012 759 citations Jonathan B. Mitchem, Donal J. Brennan et al. Cancer Research profile →
Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance

2007 726 citations Xuefang Cao, Sheng F. Cai et al. profile →
CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer

2004 586 citations Joel R. Garbow, Julie L. Prior et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Piwnica‐Worms United States	71	9.2k	5.8k	3.3k	3.0k	2.7k	282	19.5k
Beverly A. Teicher United States	67	8.7k 0.9×	7.5k 1.3×	1.8k 0.5×	2.0k 0.7×	4.2k 1.6×	396	18.1k
Keith L. Black United States	76	7.4k 0.8×	5.5k 1.0×	3.9k 1.2×	2.5k 0.8×	2.1k 0.8×	399	21.6k
Edouard C. Nice Australia	74	9.5k 1.0×	4.6k 0.8×	2.0k 0.6×	2.4k 0.8×	2.2k 0.8×	304	17.3k
Arne Östman Sweden	63	9.8k 1.1×	4.6k 0.8×	2.9k 0.9×	966 0.3×	2.9k 1.1×	165	16.8k
William H. McBride United States	66	5.7k 0.6×	6.6k 1.2×	5.3k 1.6×	3.5k 1.2×	2.1k 0.8×	305	17.1k
Paul Workman United Kingdom	85	18.6k 2.0×	5.8k 1.0×	2.3k 0.7×	2.0k 0.7×	4.4k 1.7×	535	27.7k
Rolf A. Brekken United States	73	9.3k 1.0×	6.4k 1.1×	3.5k 1.0×	950 0.3×	4.4k 1.7×	271	19.5k
Raymond Sawaya United States	84	8.4k 0.9×	7.9k 1.4×	2.5k 0.7×	3.7k 1.2×	5.0k 1.9×	351	28.2k
William E. Grizzle United States	82	14.1k 1.5×	6.3k 1.1×	3.9k 1.2×	1.7k 0.6×	6.4k 2.4×	499	26.2k
Santosh Kesari United States	63	7.6k 0.8×	4.3k 0.7×	1.5k 0.4×	1.6k 0.5×	4.4k 1.7×	440	18.1k

Countries citing papers authored by David Piwnica‐Worms

Since Specialization

Citations

This map shows the geographic impact of David Piwnica‐Worms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Piwnica‐Worms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Piwnica‐Worms more than expected).

Fields of papers citing papers by David Piwnica‐Worms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Piwnica‐Worms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Piwnica‐Worms. The network helps show where David Piwnica‐Worms may publish in the future.

Co-authorship network of co-authors of David Piwnica‐Worms

This figure shows the co-authorship network connecting the top 25 collaborators of David Piwnica‐Worms. A scholar is included among the top collaborators of David Piwnica‐Worms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Piwnica‐Worms. David Piwnica‐Worms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sutton, Margie N., et al.. (2024). Dimerization of the 4Ig isoform of B7-H3 in tumor cells mediates enhanced proliferation and tumorigenic signaling. Communications Biology. 7(1). 21–21. 7 indexed citations

Lytle, Nikki K., Seth T. Gammon, Tikvah K. Hayes, et al.. (2020). Analysis of RAS protein interactions in living cells reveals a mechanism for pan-RAS depletion by membrane-targeted RAS binders. Proceedings of the National Academy of Sciences. 117(22). 12121–12130. 12 indexed citations

Gammon, Seth T., Niki M. Zacharias, Tracy Liu, et al.. (2020). Hyperpolarized [1- ¹³ C]pyruvate-to-[1- ¹³ C]lactate conversion is rate-limited by monocarboxylate transporter-1 in the plasma membrane. Proceedings of the National Academy of Sciences. 117(36). 22378–22389. 50 indexed citations

Zacharias, Niki M., Natalia Baran, Sriram S. Shanmugavelandy, et al.. (2019). Assessing Metabolic Intervention with a Glutaminase Inhibitor in Real-Time by Hyperpolarized Magnetic Resonance in Acute Myeloid Leukemia. Molecular Cancer Therapeutics. 18(11). 1937–1946. 22 indexed citations

Melo, Sónia A., Christoph Kahlert, Agustín F. Fernández, et al.. (2015). Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 523(7559). 177–182. 2224 indexed citations breakdown →

Elhammali, Adnan, Joseph E. Ippolito, Lynne Collins, et al.. (2014). A High-Throughput Fluorimetric Assay for 2-Hydroxyglutarate Identifies Zaprinast as a Glutaminase Inhibitor. Cancer Discovery. 4(7). 828–839. 66 indexed citations

Alspach, Elise, Kevin C. Flanagan, Xianmin Luo, et al.. (2014). p38MAPK Plays a Crucial Role in Stromal-Mediated Tumorigenesis. Cancer Discovery. 4(6). 716–729. 134 indexed citations

Macdonald-Obermann, Jennifer L., Sangeeta Adak, Ralf Landgraf, David Piwnica‐Worms, & Linda J. Pike. (2013). Dynamic Analysis of the Epidermal Growth Factor (EGF) Receptor-ErbB2-ErbB3 Protein Network by Luciferase Fragment Complementation Imaging. Journal of Biological Chemistry. 288(42). 30773–30784. 30 indexed citations

Mitchem, Jonathan B., Donal J. Brennan, Brett L. Knolhoff, et al.. (2012). Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses. Cancer Research. 73(3). 1128–1141. 759 indexed citations breakdown →

10.

Pazolli, Ermira, et al.. (2012). Chromatin Remodeling Underlies the Senescence-Associated Secretory Phenotype of Tumor Stromal Fibroblasts That Supports Cancer Progression. Cancer Research. 72(9). 2251–2261. 152 indexed citations

11.

Flentie, Kelly, et al.. (2012). A Bioluminescent Transposon Reporter-Trap Identifies Tumor-Specific Microenvironment-Induced Promoters in Salmonella for Conditional Bacterial-Based Tumor Therapy. Cancer Discovery. 2(7). 624–637. 67 indexed citations

12.

Yang, Chang, Jennifer L. Davis, Rong Zeng, et al.. (2012). Antagonism of Inhibitor of Apoptosis Proteins Increases Bone Metastasis via Unexpected Osteoclast Activation. Cancer Discovery. 3(2). 212–223. 34 indexed citations

13.

Chen, David Y., Brian A. Van Tine, Adam C. Searleman, et al.. (2011). A Pharmacologic Inhibitor of the Protease Taspase1 Effectively Inhibits Breast and Brain Tumor Growth. Cancer Research. 72(3). 736–746. 35 indexed citations

14.

Woerner, B. Mark, Jingqin Luo, Erin Jackson, et al.. (2011). Suppression of G-protein–Coupled Receptor Kinase 3 Expression Is a Feature of Classical GBM That Is Required for Maximal Growth. Molecular Cancer Research. 10(1). 156–166. 33 indexed citations

15.

Warrington, Nicole M., Scott M. Gianino, Erin Jackson, et al.. (2010). Cyclic AMP Suppression Is Sufficient to Induce Gliomagenesis in a Mouse Model of Neurofibromatosis-1. Cancer Research. 70(14). 5717–5727. 87 indexed citations

16.

Banerjee, Sutapa, Scott M. Gianino, Scott E. Harpstrite, et al.. (2010). The Neurofibromatosis Type 1 Tumor Suppressor Controls Cell Growth by Regulating Signal Transducer and Activator of Transcription-3 Activity In vitro and In vivo. Cancer Research. 70(4). 1356–1366. 49 indexed citations

17.

Cao, Xuefang, Lynne Collins, Sheng F. Cai, et al.. (2009). Interleukin 12 Stimulates IFN-γ–Mediated Inhibition of Tumor-Induced Regulatory T-Cell Proliferation and Enhances Tumor Clearance. Cancer Research. 69(22). 8700–8709. 70 indexed citations

18.

Pazolli, Ermira, Xianmin Luo, Kelly Carbery, et al.. (2009). Senescent Stromal-Derived Osteopontin Promotes Preneoplastic Cell Growth. Cancer Research. 69(3). 1230–1239. 122 indexed citations

19.

Goldhoff, Patricia, Nicole M. Warrington, David D. Limbrick, et al.. (2008). Targeted Inhibition of Cyclic AMP Phosphodiesterase-4 Promotes Brain Tumor Regression. Clinical Cancer Research. 14(23). 7717–7725. 105 indexed citations

20.

Tan, Benjamin, David Piwnica‐Worms, & Lee Ratner. (2000). Multidrug resistance transporters and modulation. Current Opinion in Oncology. 12(5). 450–458. 329 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact